Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1116
https://www.valueinhealthjournal.com/article/S1098-3015(13)03021-0/fulltext
Section Title :
Disease-Specific Studies
Section Order :
970
First Page :
A497
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03021-0&doi=10.1016/j.jval.2013.08.1116